CANbridge and UMass Chan Medical School Spinal Muscular Atrophy Gene Therapy (CAN203) Improves Lifespan and Motor Function in Mice When Administered via Intracerebroventricular Injection

CANbridge and UMass Chan Medical School Spinal Muscular Atrophy Gene Therapy (CAN203) Improves Lifespan and Motor Function in Mice When Administered via Intracerebroventricular Injection

Business Wire

Published

BURLINGTON, Mass. & BEIJING--(BUSINESS WIRE)--Novel CANbridge/UMass spinal muscular atrophy (SMA) gene therapy improves lifespan and motor function in mice when delivered into CNS, data at ASGCT.

Full Article